Venus Concept Inc.
VERO$687,876
Micro CapNASDAQSurgical & Medical Instruments & Apparatus🇺🇸North AmericaTORONTO
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
VERO News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
CSE-1034 (Ceftriaxone + Sulbactam + EDTA) | Phase 3 | Urinary Tract Infection Complicated | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply